271 related articles for article (PubMed ID: 26975901)
21. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
Ramos P; Karnezis AN; Craig DW; Sekulic A; Russell ML; Hendricks WP; Corneveaux JJ; Barrett MT; Shumansky K; Yang Y; Shah SP; Prentice LM; Marra MA; Kiefer J; Zismann VL; McEachron TA; Salhia B; Prat J; D'Angelo E; Clarke BA; Pressey JG; Farley JH; Anthony SP; Roden RB; Cunliffe HE; Huntsman DG; Trent JM
Nat Genet; 2014 May; 46(5):427-9. PubMed ID: 24658001
[TBL] [Abstract][Full Text] [Related]
22. Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
Conlon N; Silva A; Guerra E; Jelinic P; Schlappe BA; Olvera N; Mueller JJ; Tornos C; Jungbluth AA; Young RH; Oliva E; Levine D; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):395-403. PubMed ID: 26645725
[TBL] [Abstract][Full Text] [Related]
23. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
24. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
[TBL] [Abstract][Full Text] [Related]
25. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.
David MP; Venkatramani R; Lopez-Terrada DH; Roy A; Patil N; Fisher KE
Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275002
[TBL] [Abstract][Full Text] [Related]
26. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
[TBL] [Abstract][Full Text] [Related]
27. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
Jelinic P; Schlappe BA; Conlon N; Tseng J; Olvera N; Dao F; Mueller JJ; Hussein Y; Soslow RA; Levine DA
Mod Pathol; 2016 Jan; 29(1):60-6. PubMed ID: 26564006
[TBL] [Abstract][Full Text] [Related]
28. SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report.
Sirák I; Laco J; Vošmiková H; Mell LK; Herrera FG; Šenkeříková M; Vošmik M
Pathol Oncol Res; 2021; 27():1610003. PubMed ID: 34970085
[TBL] [Abstract][Full Text] [Related]
29. Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
Lang JD; Hendricks WPD
Methods Mol Biol; 2018; 1706():367-379. PubMed ID: 29423809
[TBL] [Abstract][Full Text] [Related]
30. Ovarian small cell carcinoma in one of a pair of monozygous twins.
Fahiminiya S; Sabbaghian N; Albrecht S; Nadaf J; Callegaro-Filho D; Foulkes WD
Fam Cancer; 2019 Apr; 18(2):161-163. PubMed ID: 30284660
[TBL] [Abstract][Full Text] [Related]
31. Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.
Moes-Sosnowska J; Szafron L; Nowakowska D; Dansonka-Mieszkowska A; Budzilowska A; Konopka B; Plisiecka-Halasa J; Podgorska A; Rzepecka IK; Kupryjanczyk J
Orphanet J Rare Dis; 2015 Mar; 10():32. PubMed ID: 25886974
[TBL] [Abstract][Full Text] [Related]
32. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
Agaimy A; Thiel F; Hartmann A; Fukunaga M
Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
[TBL] [Abstract][Full Text] [Related]
33. Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade.
Jelinic P; Ricca J; Van Oudenhove E; Olvera N; Merghoub T; Levine DA; Zamarin D
J Natl Cancer Inst; 2018 Jul; 110(7):787-790. PubMed ID: 29365144
[TBL] [Abstract][Full Text] [Related]
34. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.
Jelinic P; Mueller JJ; Olvera N; Dao F; Scott SN; Shah R; Gao J; Schultz N; Gonen M; Soslow RA; Berger MF; Levine DA
Nat Genet; 2014 May; 46(5):424-6. PubMed ID: 24658004
[TBL] [Abstract][Full Text] [Related]
35. Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.
Harrison ML; Hoskins P; du Bois A; Quinn M; Rustin GJ; Ledermann JA; Baron-Hay S; Friedlander ML
Gynecol Oncol; 2006 Feb; 100(2):233-8. PubMed ID: 16321429
[TBL] [Abstract][Full Text] [Related]
36. Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with
Simões MFE; da Costa AABA; Silva TN; Fernandes L; Bovolim G; Torrezan GT; Carraro DM; Baiocchi G; Menezes ANO; Santana Dos Santos E; De Brot L
Curr Oncol; 2022 Jan; 29(2):411-422. PubMed ID: 35200537
[TBL] [Abstract][Full Text] [Related]
37. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
[TBL] [Abstract][Full Text] [Related]
38. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
[TBL] [Abstract][Full Text] [Related]
39. Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
Wang Y; Chen SY; Colborne S; Lambert G; Shin CY; Santos ND; Orlando KA; Lang JD; Hendricks WPD; Bally MB; Karnezis AN; Hass R; Underhill TM; Morin GB; Trent JM; Weissman BE; Huntsman DG
Mol Cancer Ther; 2018 Dec; 17(12):2767-2779. PubMed ID: 30232145
[TBL] [Abstract][Full Text] [Related]
40. [SCCOHT/ovarian rhabdoid tumor: A case report].
Bourgoin R; Cornelis F; Masliah-Planchon J; Genestie C; Laé M
Ann Pathol; 2019 Sep; 39(5):357-363. PubMed ID: 30928254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
